Clinical Trials in Nashville

Showing 17781-17800 of 20,298 trials

Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder

NCT00672958

The purpose of this study is to determine the efficacy and safety of once daily vortioxetine (Lu AA21004) in adults with major depressive disorder.

Major Depressive Disorder

Takeda600 participantsStarted Apr 2008

Birmingham, Alabama, United States • Cerritos, California, United States • Encino, California, United States +30 more locations

COMPLETEDPhase 4< 1 mile

PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)

NCT00274638

To demonstrate that Telmisartan combined with Hydrochlorothiazide (MICARDIS® HCT) is superior to Losartan with Hydrochlorothiazide (Hyzaar®) in lowering blood pressure in mild-moderate hypertensives.

Hypertension

Boehringer Ingelheim805 participantsStarted Jul 2002

Huntsville, Alabama, United States • Little Rock, Arkansas, United States • Carmichael, California, United States +66 more locations

Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder

PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)

Find Trials by Condition in Nashville

Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site

Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)

Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations

Interventional Management of Stroke (IMS) III Trial

VI-1121 for the Treatment Alzheimer's Disease

Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer

Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine

Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology

Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy

Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT)

Study of orBec® With Prednisone Therapy in the Treatment of Patients With Graft Versus Host Disease (GVHD)

A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)

Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel

Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments

The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial